The safety of macrolides during lactation

Breastfeeding Medicine

Volumn 4, Issue 4, 2009, Pages 197-200

  Goldstein, L H ^a   Berlin, M ^b   Tsur, L ^b   Bortnik, O ^b   Binyamini, L ^b   Berkovitch, M ^b  

^a HAEMEK MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; CLARITHROMYCIN; ERYTHROMYCIN; MACROLIDE; ROXITHROMYCIN;

ADULT; ANOREXIA; ANTIBIOTIC THERAPY; ARTICLE; BREAST FEEDING; CONTROLLED STUDY; DIARRHEA; DRUG ERUPTION; DRUG EXPOSURE; DRUG SAFETY; FEMALE; GESTATIONAL AGE; GINGIVITIS; HELICOBACTER INFECTION; HUMAN; INFANT; LACTATION; MAJOR CLINICAL STUDY; MASTITIS; PHARYNGITIS; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SOMNOLENCE;

ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; COHORT STUDIES; CONFIDENCE INTERVALS; DIARRHEA, INFANTILE; FEMALE; GESTATIONAL AGE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LACTATION; MACROLIDES; MILK, HUMAN; ODDS RATIO; PROSPECTIVE STUDIES; PYLORIC STENOSIS; RISK ASSESSMENT; RISK FACTORS; VOMITING;

EID: 70350339336     PISSN: 15568253     EISSN: None     Source Type: Journal    
DOI: 10.1089/bfm.2008.0135     Document Type: Article

References (19)

1. Atkinson HC, Begg EJ, Darlow BA. Drugs in human milk. Clinical pharmacokinetic considerations. Clin Pharmacokinet 1988;14:217-240.
2. Ito S, Blajchman A, Stephenson M, et al. Prospective followup of adverse reactions in breast-fed infants exposed to maternal medication. Am J Obstet Gynecol 1993;168:1393-1399.
3. Dillon AE, Wagner CL, Wiest D, et al. Drug therapy in the nursing mother. Obstet Gynecol Clin North Am 1997;24: 675-696.
4. Kelsey JJ, Moser LR, Jennings JC, et al. Presence of azithromycin breast milk concentrations: A case report. Am J Obstet Gynecol 1994;170:1375-1376.
5. Lassman HB, Puri SK, Ho I, et al. Pharmacokinetics of roxithromycin (RU 965). J Clin Pharmacol 1988;28:141-152.
6. Sedlmayr T, Peters F, Raasch W, et al. Clarithromycin, a new macrolide antibiotic. Effectiveness in puerperal infections and pharmacokinetics in breast milk. Geburtshilfe Frauenheilkd 1993;53:488-491.
7. SanFilippo JA. Infantile hypertrophic pyloric stenosis related to ingestion of erythromycin estolate: A report of 5 cases. J Pediatr Surg 1976;11:177-180.
8. Stang H. Pyloric stenosis associated with erythromycin ingested through breastmilk. Minn Med 1986;69:669-670.
9. Honein MA, Paulozzi LJ, Himelright IM, et al. Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromycin: A case review and cohort study. Lancet 1999;354:2101-2105.
10. Center for Disease Control and Prevention. Hypertrophic pyloric stenosis in infants following pertussis prophylaxis with erythromycin-Knoxville, Tennessee, 1999. MMWR Morb Mortal Wkly Rep 1999;48:1117-1120.
11. Mahon BE, Roseman MB, Kleiman MB. Maternal and infant use of erythromycin and other macrolide antibiotics as risk factors for infantile hypertrophic pyloric stenosis. J Pediatr 2001;139:380-384.
12. Cooper WO, Griffin MR, Arbogast P, et al. Very early exposure to erythromycin and infantile hypertrophic pyloric stenosis. Arch Pediatr Adolesc Med 2002;156:647-650.
13. Peeters T, Matthijs G,Depoortere I, Cachet T, et al. Erythromycin is a motilin receptor agonist. Am J Physiol 1989;257: G470-G474.
14. Mavromati T, Papapanagioutou D, Bursinos B, et al. Gastroduodenal: Prokinetic action of erythromycin on the operated stomach. Br J Surg 1995;82:50.
15. Jadcherla S, Klee G, Berseth C. Regulation of migrating motor complexes by motilin and pancreatic polypeptide in human infants. Pediatr Res 1997;42:365-369.
16. Hauben M, Amsden G. The association of erythromycin and infantile hypertrophic pyloric stenosis. Causal or coincidental? Drug Safety 2002;25:929-942.
17. Morrison W. Infantile hypertrophic pyloric stenosis in infants treated with azithromycin. Pediatr Infect Dis J 2007;26:186-188.
18. Srensen HT, Skriver MV, Pedersen L, et al. Risk of infantile hypertrophic pyloric stenosis after maternal postnatal use of macrolides. Scand J Infect Dis 2003;35:104-106.
19. Benyamini L, Merlob P, Stahl B, et al. The safety of amoxicillin/ clavulanic acid and cefuroxime during lactation. Ther Drug Monit 2005;27:499-502.